Endogenous opioids: The downside of opposing stress
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Our dynamic environment regularly exposes us to potentially life-threatening challenges or stressors. To answer these challenges and maintain homeostasis, the stress response, an innate coordinated engagement of central and peripheral neural systems is initiated. Although essential for survival, the inappropriate initiation of the stress response or its continuation after the stressor is terminated has pathological consequences that have been linked to diverse neuropsychiatric and medical diseases. Substantial individual variability exists in the pathological consequences of stressors. A theme of this Special Issue is that elucidating the basis of individual differences in resilience or its flipside, vulnerability, will greatly advance our ability to prevent and treat stress-related diseases. This can be approached by studying individual differences in "pro-stress" mediators such as corticosteroids or the hypothalamic orchestrator of the stress response, corticotropin-releasing factor. More recently, the recognition of endogenous neuromodulators with "anti-stress" activity that have opposing actions or that restrain stress-response systems suggests additional bases for individual differences in stress pathology. These "anti-stress" neuromodulators offer alternative strategies for manipulating the stress response and its pathological consequences. This review uses the major brain norepinephrine system as a model stress-response system to demonstrate how co-regulation by opposing pro-stress (corticotropin-releasing factor) and anti-stress (enkephalin) neuromodulators must be fine-tuned to produce an adaptive response to stress. The clinical consequences of tipping this fine-tuned balance in the direction of either the pro- or anti-stress systems are emphasized. Finally, that each system provides multiple points at which individual differences could confer stress vulnerability or resilience is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRF was initially characterized as the paraventricular hypothalamic neurohormone that initiates anterior pituitary adrenocorticotropin secretion in response to stressors (Vale et al., 1981).”
BackgroundIdentification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806 · cited 1×
“Several laboratories were involved in the discovery and characterization of the endogenous “morphine-like” peptides and their receptors in the early 1970's (Goldstein et al., 1979; Hughes et al., 1975; Ling et al., 1976; Bradbury et al., 1976; Meunier et al., 1995; Pert and Snyder, 1973).”
BackgroundThe Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“…disease, as well as medical conditions including obesity, cardiovascular disease, inflammatory disorders and irritable bowel syndrome (Chrousos, 2000a; Chrousos and Gold, 1992; de Kloet et al., 2005; Goeders, 2003; McEwen, 1998; Larauche et al., 2012; Chrousos, 2000b; McEwen and Stellar, 1993).”
BackgroundBerridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529 · cited 1×
“More detailed information about this system and its other putative functions that are outside the scope of this review can be found in (Aston-Jones et al., 1995; Foote et al., 1983; Berridge and Waterhouse, 2003).”
BackgroundAston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 3×
“1) (AstonJones and Bloom, 1981a), (Aston-Jones and Bloom, 1981a; Foote et al., 1980).”
BackgroundSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Dynorphin-(1-13), an extraordinarily potent opioid peptide.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6666 · Cited by 882 · cited 1×
“Several laboratories were involved in the discovery and characterization of the endogenous “morphine-like” peptides and their receptors in the early 1970's (Goldstein et al., 1979; Hughes et al., 1975; Ling et al., 1976; Bradbury et al., 1976; Meunier et al., 1995; Pert and Snyder, 1973).”
BackgroundFoote, S. L., Aston-Jones, G., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.3033 · Cited by 857 · cited 4×
“1) (AstonJones and Bloom, 1981a), (Aston-Jones and Bloom, 1981a; Foote et al., 1980).”
BackgroundInfluentialMaier, S. F., & Watkins, L. R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.021 · Cited by 737
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.624 · Cited by 721
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
Southwick, S. M., Bremner, J. D., Rasmusson, A., Morgan, C. A., Arnsten, A., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00219-x · Cited by 573
Convergent regulation of locus coeruleus activity as an adaptive response to stress
Valentino, R. J., & Van Bockstaele, E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.062 · Cited by 569
Self-citationBeck, C., & Fibiger, H. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00709.1995 · Cited by 547
Sex and depression in the National Comorbidity Survey. II: cohort effects
Kessler, R. C., McGonagle, K. A., Nelson, C. B., Hughes, M., Swartz, M., & Blazer, D. G. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90147-3 · Cited by 486
Morphine use after combat injury in Iraq and post-traumatic stress disorder
Holbrook, T. L., Galarneau, M. R., Dye, J. L., Quinn, K., & Dougherty, A. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903326 · Cited by 429 · cited 13×
“Consistent with this, many stress-related disorders including depression, PTSD and irritable bowel syndrome have been attributed to excessive CRF that is not counterregulated (Larauche et al., 2012; Bremner et al., 1997; Gold and Chrousos, 2002; Tache et al., 1993).”
BackgroundInfluentialRole of endogenous opioid system in the regulation of the stress response
Drolet, G., Dumont, É. C., Gosselin, I., Kinkead, R., Laforest, S., & Trottier, J.-F. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00161-0 · Cited by 421
Butler, P., Weiss, J., Stout, J., & Nemeroff, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-01-00176.1990 · Cited by 402
Makino, S., Gold, P. W., & Schulkin, J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91862-7 · Cited by 400 · cited 1×
“…paraventricular hypothalamic nucleus that initiate anterior pituitary adrenocorticotropin release, they increase CRF mRNA in neurons of the amygdala and bed nucleus of the stria terminalis that are thought to underlie behavioral aspects of the stress response (Makino et al., 1994a, 1994b).”
BackgroundVan Bockstaele, E. J., Colago, E. E. O., & Valentino, R. J. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00254.x · Cited by 311
Self-citationKorf, J., Aghajanian, G. K., & Roth, R. H. (1973) · Neuropharmacology · doi:10.1016/0028-3908(73)90024-5 · Cited by 311
Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide
Swerdlow, N. R., Geyer, M. A., Vale, W. W., & Koob, G. F. (1986) · Psychopharmacology · doi:10.1007/bf00652231 · Cited by 299
Pitman, R. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180041007 · Cited by 296 · cited 1×
“For example, the presentation of combat-related stimuli to PTSD patients produces naloxone-sensitive analgesic responses (Pitman et al., 1990; van der Kolk et al., 1989).”
BackgroundAmygdala FAAH and anandamide: mediating protection and recovery from stress
Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229 · cited 1×
“Some neuromediators that have been characterized as opposing stress include neuropeptide Y, endocannabinoids, urocortins and endogenous opioids (Bowers et al., 2012; Crowe et al., 2014; Gunduz-Cinar et al., 2013; Heilig and Thorsell, 2002; Hillard, 2014; Kozicz, 2007; Reul and Holsboer, 2002).”
BackgroundCampeau, S., & Watson, S. J. (1997) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1997.00593.x · Cited by 227 · cited 2×
“This has been studied using different stressors including shock, auditory stress, immunological stress, autonomic stressors, restraint and social stress and different endpoints including NE turnover, NE release, LC neuronal activity, c-fos expression or tyrosine hydroxylase expression (Cassens et al., 1981, 1980; Korf…”
BackgroundRole of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression
Hauger, R. L., Risbrough, V., Oakley, R. H., Olivares‐Reyes, J. A., & Dautzenberg, F. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05011.x · Cited by 217 · cited 1×
“…in brain and the subtype considered to be responsible formost effects attributed to the stress response, although some rodent models of anxiety and depression also implicate a role for CRF2 (Dautzenberg and Hauger, 2002; Hauger et al., 2009; Maier and Watkins, 2005; Risbrough et al., 2009, 2004).”
BackgroundBowers, M. E., Choi, D. C., & Ressler, K. J. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.004 · Cited by 155
CRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues
Risbrough, V. B., Geyer, M. A., Hauger, R. L., Coste, S., Stenzel-Poore, M., Wurst, W., & Holsboer, F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.205 · Cited by 49
Cited by
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
“Synaptic and behavioral effects of stress are also mediated, at least partly, through the opioid system; this is largely based on pharmacological and genetic manipulation in animal models and awaits elucidation of further mechanistic details [92, 93].”
BackgroundArnsten, A. F. T., Raskind, M. A., Taylor, F. B., & Connor, D. F. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.10.002 · Cited by 381
Keep Calm and Cuddle on: Social Touch as a Stress Buffer
Morrison, I. (2016) · Adaptive Human Behavior and Physiology · doi:10.1007/s40750-016-0052-x · Cited by 256
Neuropeptide and small transmitter coexistence: Fundamental studies and relevance to mental illness
Hökfelt, T., Barde, S., Xu, Z.-Q. D., Kuteeva, E., Rüegg, J., Le Maitre, E., Risling, M., Kehr, J., Ihnatko, R., Theodorsson, E., et al. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00106 · Cited by 139
The role of the opioid system in decision making and cognitive control: a review
van Steenbergen, H., Eikemo, M., & Leknes, S. (2019) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-019-00710-6 · Cited by 118
Metadata
- Authors
- Valentino, R. J., & Van Bockstaele, E.
- Venue
- Neurobiology of Stress
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 1
- Pages
- 23-32
- ISSN
- 2352-2895 (ISSN-L)
- OpenAlex
- W1999611267
- Cited by
- 133
- References
- 30
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.